Tickerplace logo

Tickerplace

Aclaris Therapeutics, Inc. logo

ACRSAclaris Therapeutics, Inc.

ACRS Stock Price, Valuation & Chart | Aclaris Therapeutics, Inc.

Compare
$3.280-0.21 (-6.02%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Diagnostics & Research
OverviewFinancialsDividendsRatios

ACRS Historical price chart

ACRS Key Stats

Market Capitalization482.81M
PE Ratio-5.66
EPS-0.58
Trading Volume2.46M
Today's High/Low3.46/3.25
Dividend Yield0.00
52 Week High/Low6.6/1.88
Shares Outstanding146.98M
ACRS Financial Statement
ACRS Analyst ratings
ACRS Analysis & performance metrics

ACRS Company profile

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It…

ACRS Management team

Management
Jon Jacobsen Ph.D.
Senior Vice President of Chemistry
Matthew Rothman J.D.
General Counsel & Corporate Secretary
Steve Tucker
Executive Vice President of Project Leadership
Joseph Monahan Ph.D.
Chief Scientific Officer
William C. Roberts
Senior Vice President of Corporate Communications & Investor Relations
James Loerop
Chief Business Officer
Ajay Aggarwal M.B.A., M.D.
Senior Vice President of Clinical Development
Hugh M. Davis Ph.D.COO
President, Chief Operating Officer & Director
Total 8 executives

ACRS Frequently asked questions

What is Aclaris Therapeutics, Inc. (ACRS) Stock Price?

Current stock price of Aclaris Therapeutics, Inc. (ACRS) stock is $3.280. The stock price is -6.02% lower in the session. The intraday range can be seen from this page. Volume of Aclaris Therapeutics, Inc. (ACRS) stock is 2.46M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Aclaris Therapeutics, Inc. (ACRS) stock price going up or down today?

The stock price of Aclaris Therapeutics, Inc. (ACRS) can change with earnings, company news, and overall market sentiment. Aclaris Therapeutics, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Aclaris Therapeutics, Inc. stock expensive at its current price?

Whether Aclaris Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ACRS on this page is -5.66. EPS on this page is -0.58. Compare those figures with peers and growth expectations before deciding if the current Aclaris Therapeutics, Inc. price is justified.

How has the stock price of Aclaris Therapeutics, Inc. (ACRS) performed historically?

Historical performance for Aclaris Therapeutics, Inc. (ACRS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ACRS reacted to past earnings and market events.

Should I buy Aclaris Therapeutics, Inc. (ACRS) stock, at this price?

Buying Aclaris Therapeutics, Inc. (ACRS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.